Eight More Patients Cleared for Foralumab Treatment & Crossing the Lemtrada Finish Line

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how the FDA has cleared eight more SPMS patients for treatment with foralumab nasal spray, under a special access program.

He also reads “Crossing the Lemtrada Finish Line”, a column by Ed Tobias.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/